Facultad de Enfermería y Fisioterapia Salus Infirmorum

Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey / (Record no. 15061)

MARC details
000 -LEADER
fixed length control field 02685nas a22001817a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230511124729.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m|||||r|||| 00| 0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field ta
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 171219t2006 sp ||||| |||| 00| 0 spa |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0160-6689
040 ## - CATALOGING SOURCE
Transcribing agency Salus Infirmorum
245 0# - TITLE STATEMENT
Title Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey /
Statement of responsibility, etc. Valerie S. L. Williams ; David S. Baldwin, D.M. ; Susan L. Hogue, Pharm.D. ; Sheri E. Fehnel ; Kelly A. Hollis ; and Heather M. Edin
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Bibliografía: p.209-210
520 8# - SUMMARY, ETC.
Summary, etc. Objective: Sexual dysfunction is a common side effect of antidepressant treatment, but recog-nition of the problem is variable. The aim of this study was to estimate the prevalence and impact of sexual dysfunction during antidepressant treat-ment in 2 European countries.<br/>Method: A cross-sectional survey of 502 adults in France and the United Kingdom. All participants were diagnosed with depression and taking a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI), starting within the previous 3 months. Information was gathered about other medications and conditions known to impair sexual functioning, recent changes in sexual functioning, and the impact of any changes.<br/>The Medical Outcomes Study 12-Item Short-Form Health Survey and the Arizona Sexual Experience Scale were administered to measure health status and sexual functioning. Data were collected from June to July of 2002.<br/>Results: Applying a prevalence estimate algo-rithm, 26.6% of the French sample and 39.2% of the U.K. sample were classified as having antidepressant-induced sexual dysfunction; 34.2% of men and 32.5% of women were classified with antidepressant-induced sexual dysfunction. There<br/>was no clear pattern of antidepressant-induced sexual dysfunction related to specific antidepres-sants. Patients with antidepressant-induced sexual<br/>dysfunction reported that changes in sexual functioning negatively affected their self-esteem, mood, and relationships with sexual partners. 23.8% of the French sample and 25.2% of the U.K. sample reported that they perceived that their partner was dissatisfied with their sex life.<br/>Conclusion: The prevalence of antidepressant-induced sexual dysfunction in this study is similar to previous estimates reported in the literature. The impact of antidepressant-induced sexual dysfunction is substantial and negatively affects quality of life, self-esteem, mood, and relationships with sexual partners.
773 ## - HOST ITEM ENTRY
Related parts -- 2006 v. 67, n 2, p.204-210
Title Journal of Clinical Psychiatry
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Universal Decimal Classification
Koha item type Artículo de revista
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Universal Decimal Classification     Non-fiction Revistas y artículos Revistas y artículos 11/05/2023   PP 6037 11/05/2023 11/05/2023 Artículo de revista

Powered by Koha